Figure 1.
Time–effect profiles for all pharmacodynamic measurements which resulted in a successful pharmacokinetic–pharmacodynamic analysis. ○ placebo, • scopolamine 0.5 mg i.v. VAS, visual analogue scale
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.